SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Experimental Vaccine Protects Monkeys Against Mosquito-Borne Chikungunya Virus, University of Texas Study
March 5, 2010
 · 
1 min read
Lone Star Bio
Scientists Identify New Drugs for Treating PTSD, University of Texas Study
March 5, 2010
 · 
1 min read
Biotech Bay
Hope For An Alzheimer’s Breakthrough Remains Despite Pfizer Inc.'s Dimebon’s Failure
March 5, 2010
 · 
5 min read
Biotech Bay
New Hope For Javelin Pharmaceuticals’s Pain Candidate But Safety Concerns Remain
February 26, 2010
 · 
3 min read
Lone Star Bio
Wii Video Games May Help Stroke Patients Improve Motor Function, University of Toronto Study
February 25, 2010
 · 
2 min read
Lone Star Bio
Stroke Incidence Rising Among Younger Adults, Decreasing Among Elderly, University of Cincinnati Study
February 25, 2010
 · 
2 min read
Bookmark and Share
Lone Star Bio
New University of Texas MD Anderson Cancer Center Strategy Develops 2 Prototype Drugs Against Cancer, Retinal Diseases
February 25, 2010
 · 
1 min read
Lone Star Bio
Single Men, Unhappily Married Men May Have Higher Risk Of Fatal Stroke, Tel Aviv University Study
February 25, 2010
 · 
2 min read
Lone Star Bio
Clot-Busting Drugs Effective In Patients With Unwitnessed Strokes, McMaster University Study
February 24, 2010
 · 
3 min read
Lone Star Bio
Deficits In Brain’s ‘Executive’ Skills Common With TIA, Minor Stroke, London Health Sciences Centre Study
February 24, 2010
 · 
4 min read
Load More
PRESS RELEASES
Press Releases
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction
July 12, 2024
 · 
4 min read
Press Releases
Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide
July 12, 2024
 · 
3 min read
Press Releases
Moleculin Completes End of Phase 2 Meeting with FDA for Annamycin in AML
July 10, 2024
 · 
4 min read
Press Releases
Nanoscope Therapeutics to Present at the 2024 American Society of Retina Specialists (ASRS) Annual Scientific Meeting
July 10, 2024
 · 
2 min read
Drug Development
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal aging-related neurodegeneration, Parkinson’s disease, and Alzheimer’s disease
July 10, 2024
 · 
5 min read
Drug Development
Mitsubishi Tanabe Pharma America to Feature RADICAVA ORS® (edaravone) Real-World Data at 2024 ALS Nexus Conference
July 10, 2024
 · 
7 min read
Drug Development
Bio-Path Holdings Provides Clinical Update and Expansion Plans
July 9, 2024
 · 
9 min read
News
Lexicon Board of Directors Appoints Mike Exton, Ph.D. as New Chief Executive Officer and Director
July 9, 2024
 · 
4 min read
CBIH: Unleashing the Potential of Cannabis for Tomorrow’s Medicine
July 8, 2024
 · 
5 min read
Press Releases
Io Therapeutics, Inc., announces presentation of data on induction of tumor growth inhibiting anti-cancer immune responses in multiple types of cancers by a IRX5010, a novel retinoic acid nuclear receptor agonist compound
July 8, 2024
 · 
2 min read
Load More